Better Therapeutics Reports First Quarter 2022 Financial Results and Provides Update on Key Corporate Milestones
Reported positive primary endpoint results from pivotal trial of BT-001 after 90 days of treatment for type 2 diabetes Represents a first-in-class randomized, controlled clinical trial of a prescription digital therapeutic (PDT) for treating a cardio...